In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase

被引:26
|
作者
Wei, Wenjuan [1 ]
Yang, Haifei [1 ]
Liu, Yanyan [1 ,2 ,3 ]
Ye, Ying [1 ,2 ,3 ]
Li, Jiabin [1 ,2 ,3 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Jixi Rd 218, Hefei, Peoples R China
[2] Anhui Med Univ, Inst Bacterium Resistance, Hefei, Peoples R China
[3] Anhui Ctr Surveillance Bacterial Resistance, Hefei, Peoples R China
基金
美国国家科学基金会;
关键词
Antimicrobial resistance; Acinetobacter; Synergy; Susceptibility; Combination therapy; MOLECULAR EPIDEMIOLOGY; SULBACTAM; FOSFOMYCIN; TIGECYCLINE; IMIPENEM; RIFAMPIN; MULTICENTER; INFECTION; EFFICACY; PLUS;
D O I
10.1179/1973947815Y.0000000030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fifty extensively drug-resistant Acinetobacter baumannii (XDRAB) were isolated from patients. The chequerboard microdilution method was used to determine the in vitro activities of five colistin (COL)based combinations including COL+fosfomycin (FOS), COL+rifampicin (RIF), COL+imipenem (IMP), COL+sulbactam (SUP) and COL+levofloxacin (LVX). The synergistic activity was evaluated by the fractional inhibitory concentration index (FICI). According to our results, the combination of COL was synergistic with FOS, RIF, IMP, SUP and LVX with the ratios of 50, 72, 88, 92 and 64%, respectively. When combined with COL, the other five agents showed increased antimicrobial activities. In addition, two of the combinations, COL+RIF and COL+IMP, were more active than the combinations of COL+FOS, COL+SUP and COL+LVX. More importantly, these combination regimens could exert synergistic effects at the sub-minimum inhibitory concentration (MIC) levels against XDRAB strains.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [1] In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
    Park, Gyun Cheol
    Choi, Ji Ae
    Jang, Sook Jin
    Jeong, Seok Hoon
    Kim, Choon-Mee
    Choi, In Sun
    Kang, Seong Ho
    Park, Geon
    Moon, Dae Soo
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (02) : 124 - 130
  • [2] Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China
    Li, Ying
    Guo, Qinglan
    Wang, Peng
    Zhu, Demei
    Ye, Xinyu
    Wu, Shi
    Wang, Minggui
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (01) : 101 - 108
  • [3] Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol
    Wei, Wen-juan
    Yang, Hai-fei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 321 - 326
  • [4] IN VITRO ACTIVITY OF COLISTIN OR SULBACTAM IN COMBINATION WITH FOSFOMYCIN OR IMIPENEM AGAINST CLINICAL ISOLATES OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII PRODUCING OXA-23 CARBAPENEMASES
    Santimaleeworagun, Wichai
    Wongpoowarak, Payom
    Chayakul, Pantip
    Pattharachayakul, Sutthiporn
    Tansakul, Pimpimon
    Garey, Kevin W.
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (04) : 890 - 900
  • [5] In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii
    Cordoba, J.
    Coronado-Alvarez, N. M.
    Parra, D.
    Parra-Ruiz, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) : 7316 - 7319
  • [6] Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
    Khawcharoenporn, Thana
    Pruetpongpun, Nattapol
    Tiamsak, Pimsiri
    Rutchanawech, Sasinuch
    Mundy, Linda M.
    Apisarnthanarak, Anucha
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (04) : 378 - 382
  • [7] In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model
    Khalil, Mahmoud A. F.
    Moawad, Sawsan S.
    Hefzy, Enas M.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (01) : 52 - 59
  • [8] In vitro activities of sitafloxacin tested alone and in combination with rifampin, colistin, sulbactam, and tigecycline against extensively drug-resistant Acinetobacter baumannii
    Dong, Xiaomeng
    Chen, Fengzhe
    Zhang, Yajun
    Liu, Haihong
    Liu, Yongjuan
    Ma, Lixian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8135 - 8140
  • [9] In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
    Lee, Hyukmin
    Roh, Kyung Ho
    Hong, Seong Geun
    Shin, Hee Bong
    Jeong, Seok Hoon
    Song, Wonkeun
    Uh, Young
    Yong, Dongeun
    Lee, Kyungwon
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (02) : 138 - 144
  • [10] OXA-23 and OXA-40 producing carbapenem-resistant Acinetobacter baumannii in Central Illinois
    Koirala, Janak
    Tyagi, Isha
    Guntupalli, Lohitha
    Koirala, Sameena
    Chapagain, Udita
    Quarshie, Christopher
    Akram, Sami
    Sundareshan, Vidya
    Koirala, Sajan
    Lawhorn, Jerry
    Doi, Yohei
    Olson, Michael
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 97 (01)